Literature DB >> 18023106

Sirolimus-induced drug fever and ciclosporin-induced leukencephalopathia with seizures in one liver transplant recipient.

Doris Schacherer1, Martina Zeitoun, Roland Buttner, Cornelia Gelbmann, Aiman Obed, Hans-Jurgen Schlitt, Jurgen Scholmerich, Gabi-I Kirchner.   

Abstract

We describe the first case of sirolimus-induced drug fever in a female liver transplant recipient, with a history of hepatitis C-induced end-stage liver cirrhosis in 1999. In 2005, six years after transplantation, she developed calcineurin inhibitor-induced renal function impairment. Immunosuppression was switched from tacrolimus to sirolimus. Two days after the intake of sirolimus, she developed daily fever spikes, but no infectious focus was found. Antibiotic therapy had no influence on the fever. After fourteen days, sirolimus was switched back to tacrolimus and the fever disappeared. In history, the patient developed ciclosporin-induced generalized seizures eleven days after liver transplantation, followed by the development of a motoric speech disorder. Magnetic resonance imaging (MRI) findings were consistent with leucoencephalopathy, therefore immunosuppressive therapy was changed from ciclosporin to tacrolimus and the neurologic symptoms improved significantly. Our case is the first reported case of sirolimus-induced drug fever. In addition, the patient showed the rare occurrence of ciclosporin-induced leukencephalopathy with seizures.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18023106      PMCID: PMC4250897          DOI: 10.3748/wjg.v13.45.6090

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  18 in total

1.  Use of rapamycin in a transplant patient who developed cyclosporin neurotoxicity.

Authors:  C B Hodges; H Maxwell; T J Beattie; A V Murphy; R M Jindal
Journal:  Pediatr Nephrol       Date:  2001-10       Impact factor: 3.714

2.  Everolimus-induced drug fever after heart transplantation.

Authors:  Lorenz Dorschner; Rudolf Speich; Frank Ruschitzka; Jörg D Seebach; Augusto Gallino
Journal:  Transplantation       Date:  2004-07-27       Impact factor: 4.939

3.  Late-onset fatal acute leucoencephalopathy in liver transplant recipient.

Authors:  N C Fisher; E Ruban; M Carey; M T Heafield; R J West; D H Adams
Journal:  Lancet       Date:  1997-06-28       Impact factor: 79.321

Review 4.  Sirolimus: a comprehensive review.

Authors:  B D Kahan
Journal:  Expert Opin Pharmacother       Date:  2001-11       Impact factor: 3.889

5.  Cyclosporin-associated cerebral lesions in liver transplantation.

Authors:  A P Boon; D H Adams; M P Carey; A Williams; P McMaster; E Elias
Journal:  Lancet       Date:  1988-06-25       Impact factor: 79.321

6.  Conversion to rapamycin immunosuppression in renal transplant recipients: report of an initial experience.

Authors:  J Dominguez; K Mahalati; B Kiberd; V C McAlister; A S MacDonald
Journal:  Transplantation       Date:  2000-10-27       Impact factor: 4.939

7.  Sirolimus: a potent new immunosuppressant for liver transplantation.

Authors:  C J Watson; P J Friend; N V Jamieson; T W Frick; G Alexander; A E Gimson; R Calne
Journal:  Transplantation       Date:  1999-02-27       Impact factor: 4.939

8.  Switch from calcineurin inhibitors to sirolimus-induced renal recovery in heart transplant recipients in the midterm follow-up.

Authors:  Reinaldo Bestetti; Tatiana A D Theodoropoulos; Emmanuel A Burdmann; Mário Abbud Filho; José A Cordeiro; Daniel Villafanha
Journal:  Transplantation       Date:  2006-03-15       Impact factor: 4.939

9.  CYP3A4 and P-glycoprotein activity in healthy controls and transplant patients on cyclosporin vs. tacrolimus vs. sirolimus.

Authors:  W P D Lemahieu; B D Maes; K Verbeke; Y Vanrenterghem
Journal:  Am J Transplant       Date:  2004-09       Impact factor: 8.086

10.  Neurotoxicity after orthotopic liver transplantation. A comparison between cyclosporine and FK506.

Authors:  A R Mueller; K P Platz; W O Bechstein; N Schattenfroh; G Stoltenburg-Didinger; G Blumhardt; W Christe; P Neuhaus
Journal:  Transplantation       Date:  1994-07-27       Impact factor: 4.939

View more
  4 in total

1.  Fever of unknown origin (FUO) in a renal transplant recipient due to drug fever from sirolimus.

Authors:  Sairah Sharif; May W Kong; James Drakakis; Burke A Cunha
Journal:  Infection       Date:  2016-01-30       Impact factor: 3.553

Review 2.  Neurotoxicity of immunosuppressive therapies in organ transplantation.

Authors:  Daniela Anghel; Radu Tanasescu; Ana Campeanu; Ioana Lupescu; Giulio Podda; Ovidiu Bajenaru
Journal:  Maedica (Buchar)       Date:  2013-06

3.  Elevation of blood ciclosporin levels by voriconazole leading to leukoencephalopathy.

Authors:  Qu Caihong; Liu Weimin; Zhu Jieming
Journal:  J Pharmacol Pharmacother       Date:  2013-10

4.  Current awareness: pharmacoepidemiology and drug safety.

Authors: 
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-06       Impact factor: 2.890

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.